CLASS II ONGOING Device recall · Reported 28 May 2025 · FDA Enforcement Report

BD Cathena Safety IV Catheter BD Multiguard Technology recalled

Becton Dickinson Infusion Therapy Systems is recalling BD Cathena Safety IV Catheter BD Multiguard Technology, distributed nationwide in the US. The recall was initiated on 21 Apr 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesREF/UDI-DI/Lot/Expiration: 386865/0100382903868650/4198480/30-Jun-2027, 386803/0100382903868032/4247809/31-Aug-2027, 386862/0100382903868629/4237744/31-Aug-2027
Quantity recalled262,800

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1808-2025
FDA event ID
96696
Classification
Class II
Status
Ongoing
Recall initiated
21 Apr 2025
FDA classified
21 May 2025
Reported
28 May 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

21 Apr 2025Recall initiated by company
21 May 2025Classified by FDA+30 days
28 May 2025Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Due to a manufacturing defect IV catheter may have a hole in the septum, which may result in blood leakage from the septum during insertion, which may cause blood exposure or the need for a second IV to be placed - which may result in therapy delay.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

BD Cathena Safety IV Catheter BD Multiguard Technology 18 GA x 1.25 IN, REF: 386865; BD Cathena Safety IV Catheter 20GX1.00IN STRAIGHT BC, REF: 386803; BD Cathena Safety IV Catheter BD Multiguard Technology 20 GA x 1.00 IN, 386862

Where it was distributed

Worldwide - US Nationwide distribution in the states of IN, AL, CA, FL, TX, NJ, MO, NC, NY, OH, AZ, MN, MA, WA, OK, KS, MS, LA, MD, GA, TN, NM, PA and the country of CA.

Nationwide AlabamaArizonaCaliforniaFloridaGeorgiaKansasLouisianaMassachusettsMarylandMinnesotaMissouriMississippiNorth CarolinaNew JerseyNew MexicoNew YorkOhioOklahomaPennsylvaniaTennessee

Questions about this recall

Why was it recalled?

Due to a manufacturing defect IV catheter may have a hole in the septum, which may result in blood leakage from the septum during insertion, which may cause blood exposure or the need for a second IV to be placed - which may result in therapy delay.

Which lots are affected?

REF/UDI-DI/Lot/Expiration: 386865/0100382903868650/4198480/30-Jun-2027, 386803/0100382903868032/4247809/31-Aug-2027, 386862/0100382903868629/4237744/31-Aug-2027

Where was it sold?

Worldwide - US Nationwide distribution in the states of IN, AL, CA, FL, TX, NJ, MO, NC, NY, OH, AZ, MN, MA, WA, OK, KS, MS, LA, MD, GA, TN, NM, PA and the country of CA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Becton Dickinson Infusion Therapy Systems

All 15

Other Heart & Vascular Devices recalls

All 6,199